Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington’s disease

Author： Zucker Birgit   Ludin Dagmar   Gerds Thomas   Lücking Carl   Landwehrmeyer G.   Feuerstein Thomas  

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.370, Iss.2, 2004-08, pp. : 131-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-08 ,pp. : 455-470

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotection in Huntington;s Disease

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite

Galantamine improves motor and psychiatric symptoms in Huntington's disease

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Therapeutic strategies in Huntington’s disease

By Alberch Jordi   Canals Josep M   Pérez-Navarro Esther  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite

Gabapentin improves outcomes in chronic daily headache

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite